Why the study?
Does plasma BNP level at presentation predict fatal pulmonary embolism in patients with acute pulmonary embolism?
Does plasma BNP level at presentation predict fatal pulmonary embolism in patients with acute pulmonary embolism?
Plasma BNP levels at presentation can predict adverse outcomes and identify low-risk patients with acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
BNP may identify low-risk acute PE patients; leaves open whether thresholds should guide management.
BACKGROUND: Despite effective treatment with anticoagulants, 2% to 7% of patients with pulmonary embolism will die as a result of their disease. METHODS AND RESULTS: We examined in 110 consecutive patients with pulmonary embolism whether plasma brain natriuretic peptide (BNP), a novel marker of (right) ventricular dysfunction, is a predictor of fatal pulmonary embolism. The relationship between BNP concentration measured at presentation and clinical outcome was assessed by comparing the proportion of outcome events among tertiles. Positive and negative predictive values of BNP levels in the highest and lowest tertiles were calculated. The risk of death related to pulmonary embolism if the BNP level is >21.7 pmol/L is 17% (95% CI, 6% to 33%). The negative predictive value for uneventful outcome of a BNP value <21.7 pmol/L is 99% (95% CI, 93% to 100%). CONCLUSIONS: This is the first study to show that plasma BNP levels seem to predict adverse outcome in patients with acute pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Wolde et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: